Talphera, Inc. (TLPH)
NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous Close | 0.7710 |
| Open | 0.7800 |
| Bid | 0.7565 x 100 |
| Ask | 0.8123 x 100 |
| Day's Range | 0.7700 - 0.8287 |
| 52 Week Range | 0.4300 - 1.6100 |
| Volume | |
| Avg. Volume | 67,326 |
| Market Cap | 13.424M |
| Beta (5Y Monthly) | 0.32 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.6300 |
| Earnings Date | Nov 06, 2024 - Nov 11, 2024 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 4.17 |
PR NewswireTalphera to Participate in the H.C. Wainwright 26th Annual Global Investment Conference
Talphera, Inc. (Nasdaq: TLPH), ("Talphera"), a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for use in medically supervised settings, today announced that management will participate in the H.C. Wainwright 26th Annual Global Investment Conference and will be taking 1x1 meetings.
- PR Newswire
Talphera Announces First Patient Enrolled in the Registrational Trial Evaluating Nafamostat for Anticoagulation of the Extracorporeal Circuit
Talphera, Inc. (Nasdaq: TLPH), ("Talphera"), a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for use in medically supervised settings, today announced the first patient has been enrolled in the NEPHRO CRRT study.
Simply Wall St.Talphera First Half 2024 Earnings: US$0.31 loss per share (vs US$0.40 loss in 1H 2023)
Talphera ( NASDAQ:TLPH ) First Half 2024 Results Key Financial Results Net loss: US$7.78m (loss widened by 78% from 1H...
© 2024 Yahoo. All rights reserved.